🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Jalyn

Found 13 matching trials

Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

PHASE3

The purpose of this study is to assess the safety and efficacy of the DTT10...

Status

Not Yet Recruiting

Location

EMS

Start Date

2025-02

Trial ID

NCT06264414

Treatments Being Tested

DTT106 Dutasteride-Tamsulosin

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia

PHASE4

Open-label, 6 month-treatment with the IP in all subjects. - Sample size: A...

Status

Terminated

Location

GSK Investigational Site

Start Date

2012-06-29

Trial ID

NCT01673490

Treatments Being Tested

Dutasteride/Tamsulosin

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.

PHASE1

This study aims to determine the relative bioavailability of tamsulosin hyd...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-06-30

Trial ID

NCT01471678

Treatments Being Tested

Dutasteride (0.5mg)FDC product of dutasteride (0.5mg) and tamsulosin HCl (0.2mg)Harnal D Tablets and Harnal Capsules (both comprising 0.2 mg tamsulosin HCl)

The Efficacy of Nano-water in Combination With Tamsulosin- Dutasteride for Lower Urinary Tract Symptoms

The goal of this clinical trial is to learn if nano-water combined with tam...

Status

Completed

Location

College of Medicine

Start Date

2016-02-16

Trial ID

NCT06677177

Treatments Being Tested

Nano-water, Tamsulosin Dutasteride Regular water, tamsulosin, Dutasteride

Bioequivalence - Duodart Against Avodart & Omnic

PHASE1

Open-label, randomized, single dose, two-treatment, two-way crossover study...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-08-23

Trial ID

NCT01657851

Treatments Being Tested

dutasteride/tamsulosin dutasteride tamsulosin

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State

PHASE1

The purpose of this study is to assess the bioequivalence of the second gen...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-02-19

Trial ID

NCT02052713

Treatments Being Tested

Commercially available combination of dutasteride 0.5 mg and tamsulosin HCL 0.4 mg Second generation dutasteride 0.5 mg and tamsulosin HCL 0.4 mg combination capsule

Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States

PHASE1

This study will be an open-label, randomized, single dose, three way crosso...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-07-10

Trial ID

NCT02184585

Treatments Being Tested

Treatment sequence A Treatment sequence B Treatment sequence C

JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

PHASE3

Benign Prostatic Hyperplasia (BPH) describes a common medical condition in ...

Status

Terminated

Location

Centre for Applied Urological Research

Start Date

2013-04

Trial ID

NCT01830829

Treatments Being Tested

Jalyn Placebo

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.

PHASE1

This study will be an open-label, randomized, single dose, two-period cross...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-09-10

Trial ID

NCT01254071

Treatments Being Tested

Dutasteride (0.5mg); Tamsulosin hydrochloride (0.2mg); fixed dose combination product of duatsteride (0.5mg) and tamsulosin hydrochloride (0.2mg)

This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples

PHASE1

This will be an open-label, three-period, fixed-sequence study to evaluate ...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-10-25

Trial ID

NCT01957189

Treatments Being Tested

Dutasteride and Tamsulosin

Previous Next